Xidong Gu

404 total citations
20 papers, 322 citations indexed

About

Xidong Gu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xidong Gu has authored 20 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Xidong Gu's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Xidong Gu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Xidong Gu collaborates with scholars based in China, United States and United Kingdom. Xidong Gu's co-authors include Xiaohong Xie, Hong Zhao, Jingjing Gu, Chang Bao, Chenggong Li, Jiaying Shen, Jie Pan, Donghai Jiang, Jue Tu and Danni Chen and has published in prestigious journals such as Scientific Reports, Cell Death and Differentiation and Cancer Letters.

In The Last Decade

Xidong Gu

17 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xidong Gu China 9 232 206 57 20 20 20 322
Xiaohong Xie China 9 278 1.2× 247 1.2× 59 1.0× 29 1.4× 12 0.6× 17 361
Manuel Schlimpert Germany 10 199 0.9× 103 0.5× 83 1.5× 21 1.1× 34 1.7× 14 341
Shuai Kong China 11 211 0.9× 102 0.5× 53 0.9× 25 1.3× 21 1.1× 26 335
Nurmaa K. Dashzeveg Japan 10 243 1.0× 141 0.7× 130 2.3× 32 1.6× 27 1.4× 12 368
Ziyi Wang China 12 322 1.4× 167 0.8× 56 1.0× 36 1.8× 22 1.1× 39 409
Lara Hasan Switzerland 5 295 1.3× 274 1.3× 31 0.5× 19 0.9× 12 0.6× 5 393
Tuan M. Nguyen United States 10 417 1.8× 109 0.5× 72 1.3× 37 1.9× 5 0.3× 14 500
Noa Stettner Israel 5 231 1.0× 163 0.8× 30 0.5× 41 2.0× 30 1.5× 7 358
Kailiang Qiao China 9 328 1.4× 151 0.7× 78 1.4× 34 1.7× 40 2.0× 15 445

Countries citing papers authored by Xidong Gu

Since Specialization
Citations

This map shows the geographic impact of Xidong Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xidong Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xidong Gu more than expected).

Fields of papers citing papers by Xidong Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xidong Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xidong Gu. The network helps show where Xidong Gu may publish in the future.

Co-authorship network of co-authors of Xidong Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xidong Gu. A scholar is included among the top collaborators of Xidong Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xidong Gu. Xidong Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Tianhua, et al.. (2025). Infection Leading to Breast Abscess Formation in Pregnancy: A Case Report. International Medical Case Reports Journal. Volume 18. 791–809.
3.
Gu, Xidong, et al.. (2025). Fungal diversity and network analysis in rhizosphere soil of Atractylodes macrocephala across different cultivation regions. Scientific Reports. 15(1). 19889–19889. 1 indexed citations
4.
Samuels, Mark, et al.. (2025). CRISPR screening approaches in breast cancer research. Cancer and Metastasis Reviews. 44(3). 59–59.
5.
6.
Shi, Qian, Lihui Xu, Jie Gu, et al.. (2024). Targeting ion channels: innovative approaches to combat cancer drug resistance. Theranostics. 15(2). 521–545. 8 indexed citations
7.
Gao, Quan, Hao Wu, Min Chen, et al.. (2024). Active metabolites combination therapies: towards the next paradigm for more efficient and more scientific Chinese medicine. Frontiers in Pharmacology. 15. 1392196–1392196. 4 indexed citations
8.
Gu, Xidong, et al.. (2024). Elemene Injection Overcomes Paclitaxel Resistance in Breast Cancer through AR/RUNX1 Signal: Network Pharmacology and Experimental Validation. Current Pharmaceutical Design. 30(29). 2313–2324. 1 indexed citations
9.
10.
11.
Hu, Yuanyuan, Xidong Gu, Yin Duan, Yong Shen, & Xiaohong Xie. (2020). Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma. Oncology Letters. 20(1). 113–122. 5 indexed citations
12.
Shen, Jian, et al.. (2019). Interference of miR-943-3p with secreted frizzled-related proteins4 (SFRP4) in an asthma mouse model. Cell and Tissue Research. 378(1). 67–80. 15 indexed citations
13.
Shen, Jiaying, Chengyong Du, Danni Chen, et al.. (2017). A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance. Cell Death and Differentiation. 25(2). 406–420. 78 indexed citations
14.
Gu, Xidong, et al.. (2017). Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway. Brazilian Journal of Medical and Biological Research. 50(7). e5920–e5920. 36 indexed citations
15.
Lu, Dezhao, et al.. (2016). Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells. Tumor Biology. 37(10). 13733–13742. 9 indexed citations
16.
Zhao, Hong, Xing Kang, Xuefeng Xia, et al.. (2016). miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.. PubMed. 8(7). 3106–14. 54 indexed citations
17.
Xie, Xiaohong, Yuanyuan Hu, Jue Tu, et al.. (2015). The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer. Tumor Biology. 36(9). 7185–7194. 54 indexed citations
18.
Sui, Xinbing, Xian Wang, Weidong Han, et al.. (2015). MicroRNAs-mediated cell fate in triple negative breast cancers. Cancer Letters. 361(1). 8–12. 19 indexed citations
19.
Sui, Xinbing, Jing Zhu, Haimei Tang, et al.. (2015). p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin. Oncotarget. 6(26). 22869–22879. 18 indexed citations
20.
Gu, Xidong & Qin Zhang. (2007). Clinical progress in the treatment of severe acute pancreatitis with integrative Chinese and Western medicine. Chinese Journal of Integrative Medicine. 13(3). 235–240. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohong Xie Breakdown of academic impact, for papers by Manuel Schlimpert Breakdown of academic impact, for papers by Shuai Kong Breakdown of academic impact, for papers by Nurmaa K. Dashzeveg Breakdown of academic impact, for papers by Ziyi Wang Breakdown of academic impact, for papers by Lara Hasan Breakdown of academic impact, for papers by Tuan M. Nguyen Breakdown of academic impact, for papers by Noa Stettner Breakdown of academic impact, for papers by Kailiang Qiao
Rankless by CCL
2026